the Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
NCT Number: NCT07142993
This is a randomized controlled study to evaluate the effectiveness of a social media-based (WeChat) networked nursing follow-up intervention compared to conventional nursing care for patients with atopic dermatitis. The study aims to determine the impact of the intervention on itch severity, skin condition, and self-care ability over a 6-month period.
Looking for future studies?
Notify Me20 year–60 year
All sexes
Interventional
Not applicable
Shijiazhuang, Hebei, 050000, China
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that requires long-term management. Traditional outpatient care is often insufficient for managing the chronic nature of the disease. This study explores the effects of social media-based networked follow-up nursing interventions, leveraging popular platforms like WeChat to provide continuous support, personalized care plans, remote monitoring, and health education. This study prospectively enrolled and randomized 100 patients with AD into two groups: a research group receiving the social media-based intervention and a control group receiving conventional nursing care. The primary objective is to compare the differences in itch severity, eczema area and severity index (EASI), overall disease assessment (IGA), and self-care ability between the two groups from baseline to 6 months post-intervention. The study aims to provide evidence for social media-based nursing as an effective adjunctive management strategy for improving outcomes in patients with atopic dermatitis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A structured nursing follow-up program delivered through a WeChat group. The program included regular sharing of educational content (articles, videos), personalized care advice, remote photo-based monitoring by medical staff, and peer support within the group. The intervention was managed by a dedicated team of dermatologists and nurses.
A standard care follow-up protocol involving verbal education at discharge, provision of printed health materials, and proactive weekly telephone calls to monitor the patient's condition, correct improper self-care actions, and encourage clinic visits if necessary.
Time frame: Baseline, 6 Months
Measured by the Numeric Rating Scale (NRS) for itching. The scale ranges from 0 (no itching) to 10 (very severe itching), where patients rate the most severe itching experienced in the past 24 hours. A higher score indicates more severe itching.
Time frame: Baseline, 6 Months
Measured by the Exercise of Self-Care Agency Scale (ESCA). The scale includes 43 items across four dimensions (self-care skills, self-responsibility, self-concept, and health knowledge). It uses a Likert 5-point scoring system (0 to 4 points). A higher total score indicates stronger self-care ability.
Time frame: Baseline, 6 Months
EASI is used to evaluate the eczema area and severity. It assesses four clinical signs (erythema, papules/edema, lichenification, epidermal peeling) on a scale of 0 to 3 based on severity. A higher score indicates greater disease severity.
Time frame: Baseline, 6 Months
Measured by the Investigator's Global Assessment (IGA). A six-level scoring system (0 to 5) is used, where 0 indicates no lesions and 5 indicates very severe disease. A higher score indicates greater overall disease severity.
The First Hospital of Hebei Medical University
Other
Impact of Social Media-Based Networked Follow-up Nursing Intervention on Itch Severity and Self-care Ability in Patients With Atopic Dermatitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06687512
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Ahmedabad, Gujarat, India
View Trial DetailsNCT05613062
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hong Kong
View Trial DetailsNCT05633355
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Phoenix, Arizona, United States
View Trial DetailsNCT05899816
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Scottsdale, Arizona, United States
View Trial Details